Delivering smarter solutions, faster.
"If you want to be a part of the most exciting transformation in the way we treat autoimmune diseases, with the company that has an outstanding Immunology pipeline, this is that once in a lifetime opportunity."
Marek Honczarenko
VP, Global Immunology Development, AbbVie
Are you interested?
Our science impacts lives. You can too.
We're dedicated to finding new ways to bring relief to people around the world living with debilitating, immune-mediated inflammatory conditions. Our portfolio focuses on assets with the potential to advance the standard of care in core disease areas, such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. We are also exploring new areas that focus on patients who have few treatment options. Our portfolio also includes assets being studied in atopic dermatitis, uveitis and hidradenitis suppurativa.
Learn more about our immunology developments, along with our pipeline and focus areas.
Aileen Pangan
Executive Medical Director, Immunology Clinical Development, AbbVie
Search all immunology job openings by area.
"Why I Joined AbbVie"
From being part of a culture that supports innovative research to making an impact on people worldwide, there are many reasons people want to work here. Hear why members of our immunology team chose AbbVie, in their own words.
Fabio Cataldi, M.D.,Group Medical Director, Gastroenterology/Immunology, Cambridge, Massachusetts
"AbbVie has been the immunology leader in cutting-edge research and innovative therapies. Plus, it fosters a collaborative culture and focused on developing talent."
Javier Maldonado, Rheumatology Sales Representative
"AbbVie is constantly evolving and positioning itself to marketplace relevancy. Anyone looking for an opportunity to be part of a company with direct impact and change has a place here at AbbVie."
Come Make a Difference
Work alongside the brightest minds to change the story for people with autoimmune diseases. The pioneering spirit of our commercial team supports our rapidly advancing pipeline – and is challenging the status quo.